Smith & Nephew (LON:SN) Share Price Crosses Above 200-Day Moving Average – Time to Sell?

Smith & Nephew plc (LON:SN) crossed above its two hundred day moving average during trading on Tuesday . The stock has a two hundred day moving average of GBX 1,037.30 ($14.00) and traded as high as GBX 1,127 ($15.22). Smith & Nephew shares last traded at GBX 1,107.50 ($14.95), with a volume of 1,028,306 shares trading hands.

Smith & Nephew Trading Up 0.9%

The firm’s 50-day simple moving average is GBX 1,040.12 and its 200-day simple moving average is GBX 1,037.30. The company has a quick ratio of 0.84, a current ratio of 2.51 and a debt-to-equity ratio of 70.22. The firm has a market capitalization of £12.26 billion, a PE ratio of 40.25, a price-to-earnings-growth ratio of 0.46 and a beta of 0.62.

Insider Buying and Selling at Smith & Nephew

In other news, insider Jeremy (Jez) Maiden bought 1,855 shares of the company’s stock in a transaction dated Thursday, May 1st. The stock was bought at an average cost of GBX 1,070 ($14.45) per share, for a total transaction of £19,848.50 ($26,796.95). Also, insider Sybella Stanley bought 3,810 shares of the company’s stock in a transaction dated Wednesday, March 26th. The shares were purchased at an average price of GBX 1,101 ($14.86) per share, with a total value of £41,948.10 ($56,633.05). Company insiders own 0.19% of the company’s stock.

Smith & Nephew Company Profile

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally. It operates through three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products.